Blood coagulation factor VII activity and the risk of myocardial infarction: The novel identification of a genetic protection that can be mimicked by an old drug

Giornale Italiano di Cardiologia

Volumn 28, Issue 6, 1998, Pages 718-721

  Iacoviello, Licia ^a,b   Donati, Maria Benedetta ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b Dipto di Med e Farmacol Vascolare   (Italy)

Author keywords

Coagulation; Myocardial infarction

Indexed keywords

BLOOD CLOTTING FACTOR 7;

BLOOD CLOTTING; CARDIOVASCULAR RISK; DNA POLYMORPHISM; EDITORIAL; GENETIC RISK; GENOTYPE; HEART INFARCTION; HUMAN;

ALLELES; ANTICOAGULANTS; CORONARY DISEASE; FACTOR VII; GENOTYPE; HUMANS; MYOCARDIAL INFARCTION; POLYMORPHISM, GENETIC; RISK FACTORS; WARFARIN;

EID: 0031750021     PISSN: 00465968     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (22)

1. MEADE TW, BROZOVIC M, CHAKRABARTI RR, ET AL Haemostatic function and ischaemic heart disease, principal results of the Northwick Park Heart Study Lancet 1986, 2 533-537
2. MEADE TW, RUDDOCK V, STIRLING Y, CHAKRABARTI R, MILLER GJ: Fibrinolytic activity, clotting factors and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study Lancet 1993, 342 1076-1079
3. HEINRICH J, BALLEISEN L, SCHULTE H, ASSMANN G, VAN DE Loo J Fibrinogen and factor VII in the prediction of coronary risk Results from the PROCAM study in healthy men Arterioscler Thromb 1994, 14 54-59
4. CORTELLARO M, BOSCHETTI C, COFRANCESCO E, ET AL The PLAT study hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients Principal results Arterioscler Thromb 1992, 12 1063-1070
5. VAZIRI ND, KENNEDY SC, KENNEDY D, GONZALES E Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris Am J Med 1992; 93 651-657
6. JUNKER R, HEINRICH J, SCHULTE H, VAN DE LOO J, ASSMANN G. Coagulation factor VII and the risk of coronary heart disease in healthy men Arterioscler Thromb Vasc Biol 1997, 17 1539-1544
7. ANNEX BH, DENNING SM, CHANNON KM, ET AL. Differential expression of tissue factor protein in directional atherectomy specimens from patients with stable and unstable coronary syndromes Circulation 1995, 91 619-622
8. ARDISSINO D, MERLINI PA, ARIENS R, COPPOLA R, BRAMUCCI E, MANNUCCI PM Tissue-factor antigen and activity in human coronary atherosclerotic plaques Lancet 1997, 349: 769-771
9. HUFFMAN CJ, MILLER RH, HULTIN MB. Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults Arterioscler Thromb 1992, 12 267-270
10. BALLEISEN L, BAILEY J, EPPING P-H, SCHULTE H, VAN DE Loo J Epidemiological study on factor VII, factor VIII and fibrinogen in an industrial population I. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill-using, and menopause Thromb Haemost 1985, 54: 475-479
11. GREEN F, KELLEHER C, WILKES H, TEMPLE A, MEADE T, HUMPHRIES S. A common genetic polymorphism associated with lower coagulation factor VII levels in healthy individuals Arterioscler Thromb 1991, 11: 540-546
12. BERNARDI F, MARCHETTI G, PINOTTI M, ET AL Factor VII gene polymorphisms contribute about one third of the factor VII level variation in plasma Arterioscler Thromb Vasc Biol 1996; 16: 72-76
13. SAHA N, LIU Y, HENG CK, HONG S, Low PS, TAY JSH Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides Arterioscler Thromb 1994, 14 1923-1927
14. HEYWOOD DM, OSSEI-GERNING N, GRANT PJ. Association of factor VII c levels with environmental and genetic factors in patients with ischaemic heart disease and coronary atheroma characterized by angiography Thromb Haemost 1996, 76: 161-165.
15. MENNEN LI, DE MAAT MPM, SCHOUTEN EG, ET AL. Coagulation factor VII, serum triglycerides and the R/Q353 polymorphism difference between older men and women Thromb Haemost 1997, 78: 984-986
16. DE MAAT MPM, GREEN F, DE KNIJFF P, JESPERSEN G, KLUFT C Factor VII polymorphisms in populations with different risk of cardiovascular disease Arterioscler Thromb Vasc Biol 1997, 17 1918-1923
17. ROVELLI F, TOGNONI G. The health service as a laboratory Lancet 1996, 348 169-170
18. IACOVIELLO L, DI CASTELNUOVO A, DE KNIJFF P, ET AL Polymorphism in the coagulation factor VII gene and risk of myocardial infarction N Engl J Med 1998, 338 79-85
19. BERNARDI F, ARCIERI P, CHIAROTTI F, ET AL Contribution of factor VII genotype to activated FVII levels Differences in genotype frequencies between Northern and Southern European populations Arterioscler Thromb Vasc Biol 1997, 17 2548-2553
20. GRUPPO ITALIANO PER LO STUDIO DELLA SOPRAVVIVENZA NELL'INFARTO MIOCARDICO GISSI-2 A factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12490 patients with acute myocardial infarction Lancet 1990, 336 65-71
21. RONCAGLIONI MC, SANTORO L, D'AVANZO B, ET AL Role of family history in patients with myocardial infarction an Italian case-control study Circulation 1992; 85 2065-2072
22. THE MEDICAL RESEARCH COUNCIL'S GENERAL PRACTICE RESEARCH FRAMEWORK. Thrombosis prevention trial, randomised trial of low-intensity oral anticoagulation with warfarin and low-dose aspirin in the primary prevention of ischaemic heart disease in men at increased risk Lancet 1998, 351 233-241